{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:51:02Z","timestamp":1784951462928,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273793"],"award-info":[{"award-number":["82273793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["JYTZD2023134"],"award-info":[{"award-number":["JYTZD2023134"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109005","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T17:55:40Z","timestamp":1758131740000},"page":"109005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design and synthesis of Prostanoid EP4 receptor antagonists for treatment of inflammatory pain"],"prefix":"10.1016","volume":"165","author":[{"given":"Huashen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junning","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.109005_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd1034","article-title":"The development of COX-2 inhibitors","volume":"2","author":"Flower","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109005_bb0010","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N","volume":"343","author":"Bombardier","year":"2000","journal-title":"Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109005_bb0015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.109005_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106847","article-title":"Discovery of (S)-flurbiprofen-based novel azine derivatives as prostaglandin endoperoxide synthase-II inhibitors: synthesis, in-vivo analgesic, anti-inflammatory activities, and their molecular docking","volume":"141","author":"Alam","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109005_bb0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijbiomac.2022.12.259","article-title":"Synthesis and characterization of biologically active flurbiprofen amide derivatives as selective prostaglandin-endoperoxide synthase II inhibitors: in vivo anti-inflammatory activity and molecular docking","volume":"228","author":"Alam","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109005_bb0030","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biocel.2003.08.006","article-title":"Prostanoids and prostanoid receptors in signal transduction","volume":"36","author":"Bos","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109005_bb0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109005_bb0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI0215528","article-title":"The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis","volume":"110","author":"McCoy","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109005_bb0045","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/jpet.106.105569","article-title":"Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity","volume":"319","author":"Lin","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109005_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/jpet.107.134510","volume":"325","author":"Clark","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109005_bb0055","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.ATV.0000177814.41505.41","article-title":"Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human","volume":"25","author":"Cipollone","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109005_rf0060","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/0008-5472.CAN-05-4348","article-title":"Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis","volume":"66","author":"Ma","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109005_rf0065","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/0008-5472.CAN-05-3702","article-title":"Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence","volume":"66","author":"Chell","year":"2006","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109005_rf0070","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1158\/0008-5472.CAN-06-1271","article-title":"Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109005_rf0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1158\/0008-5472.CAN-08-2677","article-title":"Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1","volume":"69","author":"Zheng","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109005_bb0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1476-5381.2009.00027.x","article-title":"BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache","volume":"156","author":"Maubach","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"27","key":"10.1016\/j.bioorg.2025.109005_bb0070","doi-asserted-by":"crossref","first-page":"18493","DOI":"10.1074\/jbc.M109.003269","article-title":"Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor","volume":"284","author":"Hoshino","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109005_bb0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1211\/jpp.60.6.0007","article-title":"Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis","volume":"60","author":"Okumura","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109005_bb0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-018-1537-8","article-title":"Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug","volume":"20","author":"Caselli","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bioorg.2025.109005_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1324347","article-title":"Prostaglandin E receptor subtype 4 signaling in the heart: role in ischemia\/reperfusion injury and cardiac hypertrophy","volume":"2016","author":"Pang","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109005_bb0090","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1021\/jm901771h","article-title":"The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist","volume":"53","author":"Blouin","year":"2010","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109005_bb0095","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.bmcl.2010.04.065","article-title":"Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain","volume":"20","author":"Colucci","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109005_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000222","article-title":"First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers","volume":"8","author":"Hong","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"3\u20134","key":"10.1016\/j.bioorg.2025.109005_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.lfs.2007.11.002","article-title":"In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist","volume":"82","author":"Murase","year":"2008","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109005_bb0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/jpet.107.122010","article-title":"CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties","volume":"322","author":"Nakao","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109005_bb0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jvim.13948","article-title":"A prospective, randomized, masked, placebo-controlled multisite clinical study of Grapiprant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis","volume":"30","author":"Rausch-Derra","year":"2016","journal-title":"J. Vet. Intern. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109005_bb0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4155\/ppa.13.15","article-title":"Prostaglandin EP4 antagonists","volume":"2","author":"Borriello","year":"2013","journal-title":"Pharm. Pat. Anal."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109005_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41589-018-0131-3","article-title":"Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface","volume":"15","author":"Toyoda","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109005_bb0130","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.bmcl.2017.03.078","article-title":"Synthesis and evaluation of 18F-labeled CJ-042794 for imaging prostanoid EP4 receptor expression in cancer with positron emission tomography","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109005_bb0135","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1021\/acs.jmedchem.8b01862","article-title":"Identification of a benzimidazolecarboxylic acid derivative (BAY 1316957) as a potent and selective human prostaglandin E2 receptor subtype 4 (hEP4-R) antagonist for the treatment of endometriosis","volume":"62","author":"B\u00e4urle","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109005_bb0140","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Arun","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109005_bb0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nchembio.1611","article-title":"Endosomal generation of cAMP in GPCR signaling","volume":"10","author":"Vilardaga","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109005_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.109.156398","article-title":"Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands","volume":"331","author":"Leduc","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109005_bb0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1021\/cb8000414","article-title":"Novel genetically encoded biosensors using firefly luciferase","volume":"3","author":"Fan","year":"2008","journal-title":"ACS Chem. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:30:56Z","timestamp":1762223456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"alternative-id":["S0045206825008855"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109005","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of Prostanoid EP4 receptor antagonists for treatment of inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109005"}}